- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 495.53M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 423M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 383.15M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $33.29M |
| Capex | Q1 2026 · Mar 31, 2026 | $522.95M |
| Capex | Q1 2026 · Mar 31, 2025 | $93.69M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$17.59M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $56.49M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.06B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.05B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $98.57M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.63B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.27B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$78.77M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $140.45M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.38B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.74B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $7.09B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.42B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.87B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.48B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.01B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.56B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.16 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.16 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$427.63M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$61.42M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$162.14M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$59.63M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $20.45M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $6.96M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.36M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $24.55M |
| Stock Issued | Q1 2026 · Oct 31, 2022 | 7.48M sh |